TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from JBM (Healthcare) Ltd. ( (HK:2161) ).
JBM (Healthcare) Limited has announced that its board of directors will meet on November 17, 2025, to review and approve the interim results for the six months ending September 30, 2025. The meeting will also consider the recommendation of an interim dividend and address any other business matters, potentially impacting the company’s financial strategy and shareholder returns.
The most recent analyst rating on (HK:2161) stock is a Buy with a HK$3.50 price target. To see the full list of analyst forecasts on JBM (Healthcare) Ltd. stock, see the HK:2161 Stock Forecast page.
More about JBM (Healthcare) Ltd.
JBM (Healthcare) Limited is a company incorporated in the Cayman Islands, operating within the healthcare industry. It focuses on providing healthcare products and services, with a market presence indicated by its listing on the Hong Kong Stock Exchange.
Average Trading Volume: 725,061
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.45B
For an in-depth examination of 2161 stock, go to TipRanks’ Overview page.